スマート吸入器の世界市場レポート 2024年

スマート吸入器市場規模は、今後数年間で力強い成長が見込まれます。2028年には23億6,000万米ドルに成長し、CAGRは9.8%となります。スマート吸入器の予測期間中に予想される成長は、慢性呼吸器疾患（CRDs）の有病率の上昇、在宅ヘルスケアソリューションに対する需要の増加、デジタルヘルスケア技術の採用拡大などの要因に起因しています。予測期間中に予想される主な動向には、スマート吸入器の技術的進歩、呼吸器健康管理のためのビッグデータ解析の活用、チップオンセンサの組み込み、センサ技術の進歩などがあり、これらはすべて、より効果的で患者にやさしい呼吸器ケアソリューションの進化に貢献しています。

慢性呼吸器疾患（CRDs）の有病率の増加は、スマート吸入器市場の成長を促進します。慢性呼吸器疾患には、気道や肺に影響を及ぼす長期的な疾患が含まれます。スマート吸入器は、喘息やCOPDなどの慢性呼吸器疾患の管理において、使用状況を追跡し、投薬量のリマインダーを提供することで重要な役割を果たしています。これにより、一貫した薬の使用が保証され、症状のコントロールや増悪の予防に役立ちます。オーストラリアでは、2023年6月にAustralian Institute of Health and Welfareが報告したように、呼吸器疾患関連の死亡者数は2020年の43,031人から2021年には46,551人に増加しています。さらに、2022年9月のランセット誌のデータでは、2021年に11,255人の呼吸器合胞体ウイルス（RSV）の新規患者が発生したことが明らかになった。CRDの有病率の上昇は、スマート吸入器市場の重要な促進要因です。

スマート吸入器市場の主要企業は、デジタル呼吸器健康ソリューションなどの先進技術を積極的に開発し、より多くの顧客基盤に対応し、売上を増やし、収益を高めています。デジタル呼吸器健康ソリューションは、デジタル手段を通じて呼吸器健康状態に対処し管理するように設計された技術的介入またはプラットフォームを指します。2022年2月、Aptar Pharmaは、デジタル呼吸器健康ソリューションとして機能するアドオン接続デバイス、HeroTracker Senseを発表しました。このデバイスは、標準的な定量噴霧式吸入器（MDI）をスマートコネクテッドヘルスケアデバイスに変身させ、慢性呼吸器疾患患者の生活改善に重点を置いています。MDIキャニスターに装着されるHeroTracker Senseは、吸入調整、流量、持続時間を追跡するセンサーを備えています。コンパニオンアプリを通じて情報を提供し、温度や湿度などの環境モニタリングアラートとともに、日時スタンプによる投薬リマインダーを提供します。このデバイスは、十分な情報を得た上で服薬に従うことを促進することで、処方された治療に対する患者のアドヒアランスを高めることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のスマート吸入器市場：タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 乾燥粉末吸入器（DPI）
• 定量噴霧式吸入器（MDI）
• 世界のスマート吸入器市場：適応症別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 喘息
• 慢性閉塞性肺疾患（COPD）
• その他の適応症
• 世界のスマート吸入器市場：流通チャネル別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のスマート吸入器市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院
• 在宅ケア環境
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界のスマート吸入器市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界のスマート吸入器市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• スマート吸入器市場：競合情勢
• スマート吸入器市場：企業プロファイル
  • Novartis AG
  • AstraZeneca Plc
  • GlaxoSmithKline Plc.
  • 3M Health Care Limited
  • Boehringer Ingelheim International GmbH

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Berry Global Group Inc.
• Aptar Group Inc.
• Lupin Limited
• Findair Sp.Z.o.o.
• OPKO Health Inc.
• Nemera France SAS
• Vectura Group Limited
• Propeller Health
• Inspiro Medical Ltd.
• Biocorp Production
• Cohero Health Inc.
• Pneuma Respiratory Inc.
• Amiko Digital Health Limited
• Cognita Labs LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Smart inhalers are medical devices that incorporate connectivity with a mobile app, often through Bluetooth technology. These devices are designed to improve the user experience and offer more personalized treatment decisions for individuals dealing with chronic lung conditions, including asthma and chronic obstructive pulmonary disease (COPD). Smart inhalers aim to enhance medication adherence, monitor inhaler usage, and provide valuable insights into the patient's respiratory health through the integration of digital technologies.

The primary types of smart inhalers include dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). Dry powdered inhalers (DPIs) are a specific type of inhaler designed to deliver medications, including inhaled corticosteroids, directly into the lungs. These inhalers are utilized in the treatment of various conditions such as asthma, chronic obstructive pulmonary disease (COPD), and others. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Smart inhalers, including DPIs, are employed by various end-users, including hospitals, homecare settings, and other healthcare facilities.

The smart inhalers market research report is one of a series of new reports from The Business Research Company that provides smart inhalers market statistics, including smart inhalers industry global market size, regional shares, competitors with a smart inhalers market share, detailed smart inhalers market segments, market trends, and opportunities, and any further data you may need to thrive in the smart inhalers industry. This smart inhalers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart inhalers market size has grown strongly in recent years. It will grow from $1.48 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth observed in the historical period can be attributed to factors such as increased medical adherence among patients, a growing emphasis on patient-centric healthcare, and an increasing demand for connected healthcare devices. These elements collectively contributed to the adoption and expansion of smart inhalers during the historic period, reflecting a trend towards more patient-engaged and technology-enabled healthcare solutions.

The smart inhalers market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period for smart inhalers can be attributed to factors such as the rising prevalence of chronic respiratory diseases (CRDs), an increasing demand for home healthcare solutions, and the growing adoption of digital healthcare technologies. Major trends expected in the forecast period include technological advancements in smart inhalers, the utilization of big data analytics for respiratory health management, the incorporation of chip-on-sensors, and advancements in sensor technology, all of which contribute to the evolution of more effective and patient-friendly respiratory care solutions.

The increasing prevalence of chronic respiratory diseases (CRDs) is set to drive the growth of the smart inhaler market. Chronic respiratory diseases encompass a range of long-term conditions affecting the airways and lungs. Smart inhalers play a vital role in managing CRDs such as asthma and COPD by tracking usage and providing reminders for medication doses. This ensures consistent medication use, aiding in symptom control and preventing exacerbations. In Australia, respiratory disease-related deaths increased from 43,031 in 2020 to 46,551 in 2021, as reported by the Australian Institute of Health and Welfare in June 2023. Additionally, data from The Lancet in September 2022 revealed 11,255 new cases of respiratory syncytial virus (RSV) in 2021. The rising prevalence of CRDs is a significant driver for the smart inhaler market.

Major companies in the smart inhaler market are actively developing advanced technologies, such as digital respiratory health solutions, to cater to larger customer bases, increase sales, and boost revenue. Digital respiratory health solutions refer to technological interventions or platforms designed to address and manage respiratory health conditions through digital means. In February 2022, Aptar Pharma introduced the HeroTracker Sense, an add-on connected device serving as a digital respiratory health solution. This device transforms standard metered-dose inhalers (MDIs) into smart connected healthcare devices, focusing on improving the lives of patients with chronic respiratory diseases. HeroTracker Sense, attached to the MDI canister, features sensors to track inhalation coordination, flow rate, and duration. It provides information through a companion app, offering medication reminders with date and time stamps, along with environmental monitoring alerts such as temperature and humidity. The device aims to enhance patient adherence to prescribed therapies by facilitating informed and compliant medication intake.

In August 2022, AptarGroup Inc. acquired worldwide rights to the proprietary Orbital dry powder inhaler (DPI) from Pharmaxis Inc. for an undisclosed amount. Orbital technology is designed to deliver high-payload dry powder to the lungs without the need to reload, allowing patients to inhale powder payloads of up to 400mg in divided doses. This strategic acquisition strengthens Aptar Pharma's position in respiratory drug delivery devices and associated services. Pharmaxis Inc., an Australia-based pharmaceutical company, specializes in the development of dry powder inhalers (DPIs).

Major companies operating in the smart inhalers market report are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.

North America was the largest region in the smart inhalers market in 2023. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart inhalers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart inhalers market consists of sales of pressurized MDIs (metered-dose inhalers), breath-actuated MDIs (metered-dose inhalers), and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Inhalers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart inhalers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart inhalers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart inhalers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Dry Powdered Inhalers (DPIs); Metered Dose Inhalers (MDIs)
• 2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Other Indications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By End-User: Hospitals; Homecare Settings; Other End-Users
• Companies Mentioned: Novartis AG; AstraZeneca Plc; GlaxoSmithKline Plc.; 3M Health Care Limited; Boehringer Ingelheim International GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Inhalers Market Characteristics

3. Smart Inhalers Market Trends And Strategies

4. Smart Inhalers Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Smart Inhalers Market Size and Growth

• 5.1. Global Smart Inhalers Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Smart Inhalers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Smart Inhalers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Inhalers Market Segmentation

• 6.1. Global Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Dry Powdered Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)
• 6.2. Global Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Other Indications
• 6.3. Global Smart Inhalers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare Settings
• Other End-Users

7. Smart Inhalers Market Regional And Country Analysis

• 7.1. Global Smart Inhalers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Smart Inhalers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Inhalers Market

• 8.1. Asia-Pacific Smart Inhalers Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Inhalers Market

• 9.1. China Smart Inhalers Market Overview
• 9.2. China Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Inhalers Market

• 10.1. India Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Inhalers Market

• 11.1. Japan Smart Inhalers Market Overview
• 11.2. Japan Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Inhalers Market

• 12.1. Australia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Inhalers Market

• 13.1. Indonesia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Inhalers Market

• 14.1. South Korea Smart Inhalers Market Overview
• 14.2. South Korea Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Inhalers Market

• 15.1. Western Europe Smart Inhalers Market Overview
• 15.2. Western Europe Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Inhalers Market

• 16.1. UK Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Inhalers Market

• 17.1. Germany Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Inhalers Market

• 18.1. France Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Inhalers Market

• 19.1. Italy Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Inhalers Market

• 20.1. Spain Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Inhalers Market

• 21.1. Eastern Europe Smart Inhalers Market Overview
• 21.2. Eastern Europe Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Inhalers Market

• 22.1. Russia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Inhalers Market

• 23.1. North America Smart Inhalers Market Overview
• 23.2. North America Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Inhalers Market

• 24.1. USA Smart Inhalers Market Overview
• 24.2. USA Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Inhalers Market

• 25.1. Canada Smart Inhalers Market Overview
• 25.2. Canada Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Inhalers Market

• 26.1. South America Smart Inhalers Market Overview
• 26.2. South America Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Inhalers Market

• 27.1. Brazil Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Inhalers Market

• 28.1. Middle East Smart Inhalers Market Overview
• 28.2. Middle East Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Inhalers Market

• 29.1. Africa Smart Inhalers Market Overview
• 29.2. Africa Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Inhalers Market Competitive Landscape And Company Profiles

• 30.1. Smart Inhalers Market Competitive Landscape
• 30.2. Smart Inhalers Market Company Profiles
  • 30.2.1. Novartis AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AstraZeneca Plc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. GlaxoSmithKline Plc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. 3M Health Care Limited
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Boehringer Ingelheim International GmbH
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Smart Inhalers Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Berry Global Group Inc.
• 31.3. Aptar Group Inc.
• 31.4. Lupin Limited
• 31.5. Findair Sp.Z.o.o.
• 31.6. OPKO Health Inc.
• 31.7. Nemera France SAS
• 31.8. Vectura Group Limited
• 31.9. Propeller Health
• 31.10. Inspiro Medical Ltd.
• 31.11. Biocorp Production
• 31.12. Cohero Health Inc.
• 31.13. Pneuma Respiratory Inc.
• 31.14. Amiko Digital Health Limited
• 31.15. Cognita Labs LLC

32. Global Smart Inhalers Market Competitive Benchmarking

33. Global Smart Inhalers Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Inhalers Market

35. Smart Inhalers Market Future Outlook and Potential Analysis

• 35.1 Smart Inhalers Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Smart Inhalers Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Smart Inhalers Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer